Development and clinical evaluation of a microarray for hepatitis C virus genotyping.

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Hepatitis C virus (HCV) genotype is critical for predicting chronic hepatitis C treatment outcomes.
• Accurate and convenient HCV genotyping methods are essential for routine laboratory diagnostics.

Purpose of the Study:

• To develop and evaluate a novel oligonucleotide DNA chip for efficient HCV genotyping.
• To assess the accuracy and convenience of the DNA chip compared to direct sequencing.

Main Methods:

• Design of an oligonucleotide DNA chip with 15 probes targeting the 5'-untranslated region of HCV.
• Combined reverse transcription and asymmetric polymerase chain reaction (PCR) for amplified product generation.
• Simultaneous cohybridization of biotin-labeled PCR product and streptavidin-Cy3 conjugate.

Main Results:

• The DNA chip demonstrated 100% accuracy with commercial panels and a low detection limit of 2.8x10(2) IU/ml.
• High agreement with direct sequencing: 100% for genotype and 94.6% for subgenotype levels (106/112 patients).
• The assay reduced testing time and proved convenient for laboratory use.

Conclusions:

• The developed DNA chip is a highly accurate and efficient tool for HCV genotyping.
• This method simplifies HCV identification, potentially improving chronic hepatitis C management.
• The DNA chip shows promise for routine application in clinical diagnostic laboratories.